Tema Oncology ETF (CANC)

N/A +N/A (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

Tema_ETFs
Tema_ETFs Apr. 9 at 4:26 PM
$RSHO $CANC $HRTS
0 · Reply
TalkMarkets
TalkMarkets Apr. 8 at 10:26 PM
#Healthcare #ETFs For The Weight-Loss Drug Boom And Beyond $RSHO $HRTS $CANC https://talkmarkets.com/content/etfs/healthcare-etfs-for-the-weight-loss-drug-boom-and-beyond?post=440169
0 · Reply
MarketBeat
MarketBeat Dec. 13 at 11:20 PM
Tema Oncology ETF announces dividend of $0.1491. Payable on 12/15/2023. www.marketbeat.com/stocks/NASDAQ/CANC/dividend/ $CANC
0 · Reply
Latest News on CANC
Tema Launches Two Innovative, Active ETF Thematic Strategies: Oncology & Global Royalties

Aug 17, 2023, 9:00 AM EDT - 2 years ago

Tema Launches Two Innovative, Active ETF Thematic Strategies: Oncology & Global Royalties

Tema_ETFs
Tema_ETFs Apr. 9 at 4:26 PM
$RSHO $CANC $HRTS
0 · Reply
TalkMarkets
TalkMarkets Apr. 8 at 10:26 PM
#Healthcare #ETFs For The Weight-Loss Drug Boom And Beyond $RSHO $HRTS $CANC https://talkmarkets.com/content/etfs/healthcare-etfs-for-the-weight-loss-drug-boom-and-beyond?post=440169
0 · Reply
MarketBeat
MarketBeat Dec. 13 at 11:20 PM
Tema Oncology ETF announces dividend of $0.1491. Payable on 12/15/2023. www.marketbeat.com/stocks/NASDAQ/CANC/dividend/ $CANC
0 · Reply